Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NanoViricides Inc (NYSE MKT LLC:NNVC)

1.14
Delayed Data
As of Dec 02
 +0.02 / +1.79%
Today’s Change
0.96
Today|||52-Week Range
3.44
-3.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$66.4M

Company Description

NanoViricides, Inc. is a nano-biopharmaceutical company. The company engages in the discovery, development, and commercialization of therapeutics to advance the care of patients suffering from life-threatening viral infections. It intends to manufacture Injectable and Oral FluCide, HIVCide, Nanoviricide Eye Drops, HerpeCide, DengueCide, RabiCide as well as other drugs for pre-clinical animal studies and human clinical studies. NanoViricides was founded by Anil R. Diwan on July 25, 2000 and is headquartered in Shelton, CT.

Contact Information

NanoViricides, Inc.
1 Controls Drive
Shelton Connecticut 06484
P:(203) 937-6137
Investor Relations:

Employees

Shareholders

Mutual fund holders3.12%
Other institutional2.43%
Individual stakeholders11.58%

Top Executives

Anil R. DiwanChairman, President & Secretary
Eugene SeymourChief Executive Officer & Director
Meeta R. VyasChief Financial Officer
Randall W. BartonChief Scientific & Regulatory Officer
Jayant TatakeVice President-Research & Development